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Advances in Parametric Mapping
With CMR ImagingMichael Salerno, MD, PHD,*yz Christopher M. Kramer, MD*y
Charlottesville, VirginiaCardiac magnetic resonance imaging (CMR) is well established and considered the gold standard for
assessing myocardial volumes and function, and for quantifying myocardial ﬁbrosis in both ischemic
and nonischemic heart disease. Recent developments in CMR imaging techniques are enabling
clinically-feasible rapid parametric mapping of myocardial perfusion and magnetic relaxation
properties (T1, T2, and T2* relaxation times) that are further expanding the range of unique tissue
parameters that can be assessed using CMR. To generate a parametric map of perfusion or relaxation
times, multiple images of the same region of the myocardium are acquired with different sensitivity
to the parameter of interest, and the signal intensities of these images are ﬁt to a model which
describes the underlying physiology or relaxation parameters. The parametric map is an image of the
ﬁtted perfusion parameters or relaxation times. Parametric mapping requires acquisition of multiple
images typically within a breath-hold and thus requires specialized rapid acquisition techniques.
Quantitative perfusion imaging techniques can more accurately determine the extent of myocardial
ischemia in coronary artery disease and provide the opportunity to evaluate microvascular disease
with CMR. T1 mapping techniques performed both with and without contrast are enabling
quantiﬁcation of diffuse myocardial ﬁbrosis and myocardial inﬁltration. Myocardial edema and
inﬂammation can be evaluated using T2 mapping techniques. T2* mapping provides an assessment of
myocardial iron-overload and myocardial hemorrhage. There is a growing body of evidence for the
clinical utility of quantitative assessment of perfusion and relaxation times, although current
techniques still have some important limitations. This article will review the current imaging
technologies for parametric mapping, emerging applications, current limitations, and potential of CMR
parametric mapping of the myocardium. The speciﬁc focus will be the assessment and quantiﬁcation
of myocardial perfusion and magnetic relaxation times. (J Am Coll Cardiol Img 2013;6:806–22)
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A B B R E V I A T I O N S
A N D A C R O N YM S
AIF = arterial input function
ASL = arterial spin labeling
BOLD = blood oxygen
dependent
CAD = coronary artery disease
CFR = coronary ﬂow reserve
CMR = cardiac magnetic
resonance
ECV = extracellular volume
FFR = fractional ﬂow reserve
LGE = late gadolinium
enhancement/enhanced
MI = myocardial infarction
MOLLI = Modiﬁed Look-Locker
MPR = myocardial perfusion and
perfusion reserve
MRI = magnetic resonance
imaging
PET = positron emission
tomography
SNR = signal-to-noise ratio
SR = saturation-recovery
SSFP = steady-state free
precession
T2-Prep = T2 magnetization-
preparation
TF = tissue function
TSE = turbo spin echo
Vd = volume of distribution
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807characterization for many years, it is only with recent
improvements in magnetic resonance imaging
(MRI) scanner technology and parallel imaging
reconstruction techniques that parametric mapping
of perfusion or magnetic relaxation properties (T1,
T2, and T2*) has become clinically feasible within
a single breath-hold. To generate a parametric map
of perfusion or relaxation times, multiple images of
the same region of the myocardium are acquired with
different sensitivity to the parameter of interest, and
the signal intensities of these images are ﬁt to a
model that describes the underlying physiology or
relaxation parameters. The parametric map is an
image of the ﬁtted perfusion parameters or relaxation
times. Parametric mapping techniques are extending
the range of unique tissue parameters that can be
measured by CMR. Quantitative perfusion imaging
techniques measure myocardial perfusion and
perfusion reserve (MPR), demonstrating improved
abilities to assess the extent of myocardial ischemia in
multi-vessel disease (2). Pre- and post-contrast T1
mapping techniques can quantify diffuse myocardial
ﬁbrosis in hypertrophic and inﬁltrative cardiomyop-
athies (3–5). T2 mapping techniques are improving
quantiﬁcation of myocardial edema (6,7). Imaging of
the T2* relaxation time, which is sensitive to mag-
netic ﬁeld inhomogeneity, has become clinically
useful in evaluation of myocardial iron overload and
assessment of chelation therapy (8,9). This article
will review the current imaging techniques, emerging
applications, and the future potential and limitations
of CMR for parametric mapping of the myocardium.
It will speciﬁcally focus on assessment of myocardial
perfusion, and magnetic relaxation times (T1, T2,
and T2*).
Quantiﬁcation of Myocardial Perfusion
Most clinical perfusion imaging techniques only
assess relative differences in myocardial perfusion.
The single-photon emission computed tomogra-
phy (SPECT) literature has established that
measuring relative perfusion results in reduced
sensitivity for the detection of left-main and
3-vessel coronary artery disease (CAD) as there
may be no reference area with normal perfusion
(10,11). Furthermore, there is growing interest in
the ability to assess microvascular dysfunction in
women and patients with diabetes or chest pain
and nonobstructive CAD (12). Positron emission
tomography (PET) is considered the current
gold standard technique for quantitative perfu-
sion imaging. Studies have shown that quan-
tiﬁcation of myocardial PET improves diagnosticaccuracy and provides a useful adjunct to assess-
ment of regional perfusion abnormalities. Ab-
normal MPR by PET in the absence of
obstructive CAD is associated with adverse car-
diovascular outcomes (13). PET has a few dis-
advantages including high cost, limited ability to
obtain tracers, poor spatial resolution, and expo-
sure of patients to ionizing radiation (14). CMR
has demonstrated potential for clinical quantita-
tive perfusion imaging and would overcome some
of the aforementioned limitations of
PET for this application (15).
CMR techniques for quantitative perfusion
analysis. In order to perform absolute
quantiﬁcation of myocardial blood ﬂow, a
quantiﬁable relationship must exist between
the signal intensity changes in the image and
underlying blood ﬂow. First-pass myocar-
dial perfusion techniques utilize gadolinium
(Gd) chelates that shorten the T1 relaxation
time of water (recovery of longitudinal
magnetization) in proportion to the con-
centration of Gd using saturation-recovery
(SR) pulse sequences to impart strong T1-
weighted (W) image contrast. In regions
with normal blood ﬂow there is an increased
concentration of Gd resulting in a bright
signal in the perfusion image, whereas in
regions of reduced perfusion there are lower
concentrations of gadolinium, resulting in a
lower signal intensity. Typically 3 to 5 slice
positions are imaged in a sequential fashion
during each heartbeat over the 30 to 60 s of
the ﬁrst pass of the contrast agent. Multiple
pulse sequences have been used for perfu-
sion imaging and have their advantages and
disadvantages (14). Parallel imaging with
acceleration factors of 2 to 3 are routinely
used (16) and multiple highly accelerated
techniques have been evaluated in clinical
studies (17). More recent techniques which
exploit the spatial-temporal correlations
in the series of ﬁrst-pass perfusion imag-
ing using techniques such as SENSitivity En-
coding are enabling true 3-dimensional coverage of
the ventricle with high spatial resolution (18).
Compressed-sensing techniques, which rely on the
compressibility of image data, or image sparsity, hold
potential for even more acceleration of perfusion
image acquisition (19).While any of these techniques
can be used for quantiﬁcation of myocardial perfu-
sion, care must be taken to make sure that the tech-
niques used do not disrupt the temporal evolution of
the signal intensities.
Figure 1. Absolute Quantiﬁcation of Perfusion Using Fermi
Function Deconvolution From a Dual-Sequence Spiral
Trajectory Acquisition
(A) The myocardium is segmented to generate time intensity
curves for the myocardial tissue function (TF). (B) The signal in-
tensity is converted into concentration of gadolinium for both the
arterial input function (AIF) and tissue function prior to deconvo-
lution. (C) A pixel-by-pixel perfusion map shows uniform perfusion
of 1 ml/g/min in this normal volunteer.
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808In order to quantify myocardial perfusion, 2
essential components must be measured accurately:
1) the AIF, which quantiﬁes the concentration of Gd
delivered from the left ventricle and aorta as a
function of time; and 2) the tissue function (TF),
which is related to the accumulation of contrast
agent within the myocardium. Quantiﬁcation of the
arterial input function (AIF) requires special atten-
tion as the high concentration of Gd in the blood
pool results in signiﬁcant signal saturation resulting
in improper determination of the AIF. This problem
can be overcome using several different strategies.
One approach is using a lower dose of contrast agent;
however, this results in images with lower signal-to-
noise ratio (SNR). Another is the “dual bolus” or
“pre-bolus” technique where a low dose of Gd is used
for quantiﬁcation of the AIF and a second higher
dose of contrast is used to determine the TF (20).
This technique accurately quantiﬁes both the AIF
and TF, but it requires 2 boluses with different
contrast concentrations, which may be impractical.
A third approach involves utilization of a “dual
sequence” approach, which uses a single high dose of
contrast (21). A low resolution, low T1 sensitivity
acquisition is performed in each heartbeat to quantify
the AIF, while the standard pulse sequence is used to
quantify the TF.
Once an accurate AIF and TF have been ob-
tained, there are 2 main techniques to quantify
perfusion, multicompartment kinetic modeling, and
Fermi function deconvolution. With compart-
mental modeling, the forward ﬂux of Gd from the
blood to the myocardium (Ktrans) is taken to
represent absolute myocardial blood ﬂow (22). An
important factor that is usually neglected is that the
extraction of Gd, which is ﬂow-dependent, is
required to convert Ktrans into a measurement of
absolute perfusion. Also, the fact that Gd accumu-
lates in the extravascular space is also not frequently
accounted for by this analysis. With Fermi function
deconvolution the central volume principle is used
to describe the amount of Gd present within a re-
gion of myocardium (23). An empirical Fermi
function is used for deconvolution and the initial
amplitude of the Fermi function ﬁt is proportional
to myocardial perfusion. Figure 1 demonstrates the
quantiﬁcation of perfusion using Fermi function
deconvolution of data acquired with a dual-bolus
sequence. This technique is relatively robust to the
effects of extracellular accumulation of the contrast
agent at least during ﬁrst pass of the contrast (24).
Multiple other “model-independent techniques”
have been used for deconvolution, and recently there
have been studies comparing the relative merits ofthe different techniques (25). Both of the techniques
described previously have been shown to correlate
with myocardial perfusion over a wide range of ﬂow.
Arterial spin labeling (ASL) is an alternative
technique for quantitative perfusion, which uses the
water in blood as an endogenous contrast agent.
Figure 2. Quantitative Perfusion May Be Useful in Determining Extent of Ischemia in Multivessel Disease
(A) Visual analysis of the stress images does not show a signiﬁcant perfusion abnormality; however, quantiﬁcation shows a region of reduced
perfusion reserve corresponding to an abnormality found in the left anterior descending coronary artery at cardiac catheterization. (B)
Although visual and quantitative analysis had similar diagnostic accuracy, quantitative analysis revealed a larger area of ischemia in 3-vessel
disease as compared with single-vessel disease and may be important for quantifying the volume of ischemic myocardium. Adapted from
Patel et al. (2). CAD ¼ coronary artery disease.
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809The main limitation of ASL is poor SNR due to the
small difference between the “labeled” and non-
labeled acquisitions. This technique has been used
to detect obstructive CAD; however, there are still
some technical hurdles for the technique to have
widespread clinical applicability (26). ASL may have
utility in quantifying perfusion in more diffuse
processes such as microvascular dysfunction, which
may not require high spatial resolution.
Clinical quantitative perfusion imaging. Multiple
studies have validated CMR perfusion imaging in
experimental animal models with microspheres as
the gold standard. CMR has also been validated in
human subjects by direct comparison to PET and
invasive measures of coronary ﬂow reserve (CFR)
and fractional ﬂow reserve (FFR). A study of 19
healthy volunteers demonstrated strong correlation
of both absolute perfusion (R ¼ 0.86) and MPR
(R ¼ 0.96) between quantitative CMR using kinetic
modeling and 13N-ammonia PET. However, there
was an underestimate of peak perfusion by CMR as
compared to PET (27).
Quantitative MPR was compared to CFR as
assessed by coronary ﬂow wire in a study of 20 pa-
tients with suspected CAD. This study demonstrateda strong correlation between CMR and CFR
(R¼ 0.86) and a sensitivity of 88% and a speciﬁcity of
90% for predicting a CFR <2 (28). Quantitative
CMR was also prospectively compared to FFR in
37 patients with suspected CAD who underwent
FFR and coronary angiography (29). The study
showed a reduced MPR of 1.54 for segments with
FFR <0.75 and an MPR of 2.11 for segments with
FFR >0.75. A cutoff of 2.04 for MPR was highly
sensitive (92.9%), but not speciﬁc (56.7%), for pre-
dicting an FFR<0.75. Our group studied 41 subjects
with known or suspected CAD using quantitative
MPR by CMR as compared to x-ray angiography for
detection of CAD and delineation of the extent of
ischemic myocardium (Fig. 2) (2). While qualitative
and quantitative analysis had similar diagnostic ac-
curacy (83% vs. 80%) for detecting signiﬁcant CAD,
MPR detected a signiﬁcantly higher burden of
ischemia in 3-vessel disease as compared with single-
vessel disease (60% vs. 25%, p ¼ 0.02). For visual
analysis, there was no difference in the extent of
detected ischemia between 3-vessel and single-vessel
disease (31% vs. 21%, p ¼ 0.26). A recent study has
directly compared the performance of quantitative
CMR at 1.5- and 3-T ﬁeld strengths to detect an
Figure 3. Pixel-Wise CMR Perfusion Maps at Stress and Rest From 1 Healthy Volunteer and From 3 Patients
With Coronary Artery Disease
High-quality pixel-wise maps are feasible using nonrigid registration for motion correction. Adapted from Hsu et al. (33).
CMR ¼ cardiac magnetic resonance.
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810FFR <0.8 in 34 patients with known or suspected
CAD. This study demonstrated a higher receiver-
operating characteristic area under the curve (0.963
vs. 0.645, p < 0.001), sensitivity (90.5% vs. 61.9%),
and speciﬁcity (100% vs. 76.9%) at 3-T versus
1.5-T (30).
Current limitations and future potential. Several
factors have hampered the widespread clinical ap-
plication of quantitative perfusion CMR. One is the
limited spatial coverage (typically 3 to 4 slices) as
compared with PET. However, new imaging pulse
sequences using spatiotemporal parallel techniques
have demonstrated the potential for rapid high res-
olution and 3-dimensional coverage of the myocar-
dium (18). Furthermore, spiral or radial techniques
hold promise for further acceleration of image
acquisition (31,32). Increased ﬁeld strength from
1.5- to 3-T may also improve SNR and diagnostic
performance. The lack of robust automated tools forimage registration and quantiﬁcation has limited the
applicability of quantitative analysis to research set-
tings. However, nonrigid registration techniques
have recently been applied to perform point-by-point
quantiﬁcation (Fig. 3) (33). The ﬁnal barrier is to
demonstrate that perfusion quantiﬁcation has addi-
tional beneﬁt over visual analysis or semi-quantitative
techniques. One of the justiﬁcations for absolute
quantiﬁcation has been improved detection of
3-vessel disease; however, the improved spatial res-
olution of CMR may provide sufﬁcient gradient of
perfusion to enable adequate visual analysis. Multiple
studies have demonstrated a high diagnostic accuracy
of CMR stress imaging without the complex data
analysis required for quantiﬁcation, and the incre-
mental beneﬁt of absolute quantiﬁcation still needs to
be established in larger clinical studies (34).
Quantiﬁcation of myocardial T2* relaxation times.
Quantiﬁcation of T2* relaxation times is arguably the
Figure 4. Calculation of T2* Maps in a Normal Subject
(A) A set of gradient echo images acquired with different echo times (TE) from 2 to 18 ms are acquired. As the TE is increased the signal
intensity decreases due to static ﬁeld inhomogeneities resulting in T2* decay. (B) The data from each pixel are ﬁt to a T2* decay curve. Pixels
with longer T2* decay more slowly (pink curve) as compared to regions with shorter T2* (green curve). (C) The T2* map shows a region of
reduced T2* in the inferolateral wall, which is caused by a susceptibility artifact and can be seen even in normal subjects.
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811most clinically established quantitative CMR tissue
characterization technique as it has revolutionized the
detection and monitoring of iron-overload cardio-
myopathy. T2* is the transverse relaxation time in the
presence of static magnetic ﬁeld inhomogeneities. T2*
mapping techniques enable detection of spatially
varying differences in T2* relaxation times and can be
used to detect the presence of hemorrhage in acute
myocardial infarction (MI). T2* mapping techniques
also can detect changes in myocardial oxygenation
based on the blood oxygen dependent (BOLD) effect,
which results from the difference in magnetic state
between oxyhemoglobin (diamagnetic) and deoxy-
hemoglobin (paramagnetic) as deoxyhemoglobin
reduces the T2* of blood.
CMR techniques for quantifying myocardial T2*. To
create a myocardial T2* map, multiple images with
different sensitivities to T2* must be acquired. This
is typically achieved by collecting gradient echo im-
ages with different echo times yielding images with
signal intensities which follow a T2* relaxation curve.The most commonly used pulse sequence for data
acquisition are a multiecho segmented gradient echo
technique which typically collects data at 8 different
echo times ranging from 2 to 20 ms (Fig. 4) (35).
Image data are acquired directly after the R-wave,
which further reduces artifacts from blood ﬂow and
myocardial motion. T2* measurements have pri-
marily been measured in the intraventricular septum
as this area is typically free from magnetic suscepti-
bility artifacts which corrupt the long echo time
images, particularly in the lateral wall.
Clinical application of T2* mapping techniques. The
T2* relaxation time is shortened by magnetic ﬁeld
inhomogeneities induced by myocardial iron depo-
sition. A reduction of T2* to <20 ms is consistent
with the diagnosis of iron overload cardiomyopathy
(8). The presence of abnormal T2* is the most
important predictor of future requirement for chela-
tion therapy. Changes in the myocardial T2* have
been used as a surrogate endpoint of several clinical
trials of chelation therapy in transfusion dependent
Salerno and Kramer J A C C : C A R D I O V A S C U L A R I M A G I N G , V O L . 6 , N O . 7 , 2 0 1 3
Advances in Parametric CMR J U L Y 2 0 1 3 : 8 0 6 – 2 2
812thalassaemia major patients (9). Quantitative T2*
mapping has been applied to the detection of
myocardial hemorrhage in acute MI. In a study of 62
patients with acute reperfused MI, 62% of subjects
had evidence of microvascular obstruction seen on
late gadolinium enhanced (LGE) imaging, however
only 20% of patient had hemorrhage as indicated by
T2* <30 ms (36). T2* mapping has been used to
probe the BOLD effect in ischemic heart disease. An
early study of T2* mapping in 16 healthy volunteers
and 16 patients with known single-vessel CAD
demonstrated that volunteers had a T2* of 35 ms at
rest, which increased to 40 ms with dipyridamole
infusion due to the reduction in deoxygenated he-
moglobin during hyperemia. In subjects with single-
vessel CAD, there were regional reductions in T2* at
rest in the regions supplied by stenotic arteries, and
these differences increased signiﬁcantly during
dipyridamole (37). In another study, 46 patients with
known or suspected CAD underwent BOLD T2*
mapping at rest and during adenosine stress at 3-T.
BOLD CMR at rest demonstrated signiﬁcantly
lower T2* values for ischemic segments (26.7  11.6Figure 5. Calculation of T2 Maps Using a T2-Prep Pulse Sequence in
(A) Multiple images with T2 magnetization-preparation (T2-Prep) with dif
echo–based preparation, the myocardial signal intensity decreases due
Pixels with longer T2 (pink curve) decay more slowly than regions with
(yellow arrows and pink region of interest) in this patient. (D) The abse
atypical Takotsubo cardiomyopathy.ms) as compared with normal (31.9  11.9 ms)
segments. A stress T2* <33.8 had 78% sensitivity
and 68% speciﬁcity on a per patient basis to detect
signiﬁcant CAD (38).
Potential clinical pitfalls and solutions. Care must be
taken when interpreting regional differences in T2*
from maps as the T2* can be abnormally short in
certain regions of the heart even in normal subjects
due to macroscopic magnetic ﬁeld inhomogeneity.
This is particularly problematic in the inferolateral
wall. For assessment of iron overload, which diffusely
affects the myocardium, measurement of the T2*
time in the intraventricular septum is preferred.
Quantiﬁcation of Myocardial T2 Relaxation Times
It has been long recognized that T2 relaxation times
are sensitive to myocardial edema and are known to
be elevated in acute MI (39), myocarditis (40),
sarcoidosis (41), and in cardiac allograft rejection
(42). T2 is the relaxation time for transverse mag-
netization and is prolonged in regions of edema or
inﬂammation. The current standard T2-weighteda Patient With Atypical Takotsubo Cardiomyopathy
ferent echo times (TE) are acquired. As the TE is increased for this spin
to T2 decay. (B) The data from each pixel are ﬁt to a T2 decay curve.
shorter T2 (green curve). (C) The T2 map shows a region of edema
nce of late gadolinium enhancement (LGE) conﬁrms the diagnosis of
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813dark-blood turbo spin echo sequences (TSE)
have signiﬁcant limitations, particularly for semi-
quantitative evaluation. Factors such as incomplete
blood suppression with dark-blood techniques,
regional variations in signal intensity from coil in-
homogeneities, and signal loss from myocardial
contraction and relaxation during acquisition are
signiﬁcant challenges for this technique in clinical
practice. In addition, as T2-weighted images are
inherently nonquantitative, semiquantitative tech-
niques have relied on deﬁning abnormal T2 by
a number of standard deviations of signal intensity
over that of remote myocardium, which can be
problematic when there is no remote “normal”
reference region. In the last few years, techniques
capable of rapid measurement of the myocardial T2
relaxation time have emerged and may have impor-
tant advantages over the prior semiquantitative
techniques.
CMR techniques for quantifying T2 relaxation times. In
order to quantify myocardial T2 relaxation times,
multiple images with different sensitivities to T2
need to be acquired. This is typically achieved by
collecting spin-echo images with different echo
times yielding images with signal intensities that
follow a T2 decay curve (Fig. 5). For cardiac
T2 mapping applications 2 different types of se-
quences have been employed: 1) dark-blood TSE-
based pulse sequences; and 2) bright-blood T2
magnetization-preparation (T2-Prep)–based pulseFigure 6. T2 Mapping of Edema in Acute Myocardial Infarction
(A) T2 maps, T2-weighted, and late gadolinium enhanced (LGE) images
time was signiﬁcantly increased in the region of the infarct as comparedsequences. Both free-breathing navigator-gated
acquisition and breath-hold strategies have been
utilized.
TSE-based T2-mapping techniques collect im-
ages at multiple echo times providing multiple
points along the T2 relaxation curve for data ﬁtting.
TSE pulse sequences are sensitive to ghosting arti-
facts due to blood ﬂow and dark-blood preparation
must be utilized with these strategies. Furthermore,
these sequences have some inherent sensitivity to
motion, which needs to be accounted for to accu-
rately quantify T2. The effects of coil inhomogeneity
are eliminated during the T2 ﬁtting procedure. The
T2-prep pulse sequence consists of a spin-echo–like
preparation module to impart the T2-weighted
contrast and a readout scheme to rapidly collect
the image data (43). Typically a rapid steady-state
free precession (SSFP) readout is used, which is
less sensitive to some of the artifacts, which limit
TSE-based techniques. By acquiring multiple im-
ages, each with a different T2-Prep duration, a T2
map can be determined (Fig. 5) (44,45). These
techniques demonstrate an approximately 10%
overestimate of T2 relative to reference techniques,
likely due to the SSFP readout, which induces
mixed T1 and T2 contrast (44).
Clinical application of T2 mapping techniques. T2
mapping techniques have demonstrated utility for
evaluation of a variety of cardiac pathologies. The
edematous territory measured by T2-weightedfrom patients with acute myocardial infarction. (B) The T2 relaxation
to remote and healthy myocardium. Adapted from Verhaert et al. (6).
Figure 7. T2 Maps, T2-Weighted, and LGE Images From 3 Patients With Acute Myocarditis
T2 is increased in multiple regions of the myocardium and may show more diffuse involvement than is evident on T2-weighted images.
Adapted from Thavendiranathan et al. (7). Abbreviation as in Figure 6.
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814imaging and T2 mapping has been shown to
correlate with the region of ischemic injury in a
canine model of MI (46,47). This has stimulated
considerable clinical interest in using T2-weighted
imaging to assess myocardial salvage (48). A T2-
Prep SSFP-based mapping technique was used to
evaluate 27 patients with acute MI and 21 normal
volunteers, demonstrating that the average T2 in
edematous myocardium was 69 ms compared with
56 ms in remote (Fig. 6) and 55 ms in normal
volunteers (6). Importantly, edema was detected in
26 of 27 patients with T2 mapping, whereas
conventional short tau inversion recovery images
were negative in 7 patients and uninterpretable in
2 cases.
In a study of 30 patients, T2 mapping tech-
niques have also demonstrated increased T2 in the
involved segments of myocardium in patients with
acute inﬂammatory diseases including myocarditis
and Takotsubo cardiomyopathy (Fig. 7) (7). In
both pathologies there was no difference in the
T2 of the remote myocardium as compared withcontrols. A T2 cutoff of 59 ms had a sensitivity of
94% and speciﬁcity of 97% for identifying affected
myocardium. Conventional T2-weighted images
were uninterpretable in 7 subjects because of
artifacts and did not demonstrate abnormalities in
2 subjects with abnormal T2 values by T2 map-
ping. Bright blood T2-Prep SSFP images did
not show a clear region of increased signal in-
tensity in 13 of 30 subjects. This study demon-
strates that T2 mapping may improve the ability
to differentiate edematous myocardium over T2-
weighted techniques.
T2 mapping has also been used for the assessment
of iron-overload cardiomyopathy (49). The super-
paramagnetic properties of iron result in a short-
ening of both T2 and T2* relaxation times resulting
in more rapidly decaying transverse magnetization
which can be detected by CMR. T2 mapping has 2
potential advantages over T2* mapping in that
pulse sequences for determination of T2 are less
sensitive to static magnetic ﬁeld inhomogeneities
and typically produce images of higher SNR. In a
Figure 8. Calculation of Post-Contrast T1 Maps Using a Modiﬁed MOLLI Pulse Sequence in a Patient With Myocarditis
(A) Late gadolinium enhanced (LGE) images from an ischemic cardiomyopathy demonstrate a focal region of late gadolinium enhancement
corresponding to prior myocardial infarction. (B) This region of increased signal intensity corresponds to focal ﬁbrosis in the infarct on H&E
stained myocardium. (C) LGE images from a patient with dilated cardiomyopathy do not demonstrate any focal LGE; however (D) histological
evaluation would demonstrate diffuse interstitial ﬁbrosis that is not identiﬁable by LGE imaging.
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815study of 136 patients with thalassaemia, a linear
relationship has been demonstrated between T2
and T2* (R ¼ 0.89) in subjects with iron overload
with similar diagnostic utility for detecting iron
overload (49).
Potential clinical pitfalls and solutions. Care must
be taken when comparing absolute T2 relaxation
times between data acquired with different tech-
niques as biases in the absolute numbers may occur
between different sequences or patient-related
factors. For the T2-Prep mapping sequence, in a
tachycardiac patient, incomplete T1 relaxation be-
tween each image acquisition may introduce some
bias to the measured T2-weighted images. This
effect can be minimized by increasing the number
of heartbeats between images (i.e., from 3 to 4
relaxation beats) to enable more time for T1
relaxation. TSE-based pulse sequences can also have
some errors in accurate T2 determination by intro-
ducing some T1 dependence to the values. An
additional problem is that current mapping se-
quences have limited spatial resolution as comparedto T2-weighted images; however, this problem is
likely to be overcome by improved pulse sequences
and reconstruction techniques.
Quantiﬁcation of T1 Relaxation Times and
Volume of Distribution of Gadolinium
LGE imaging has become the gold standard tech-
nique for imaging focal myocardial ﬁbrosis in CAD
and nonischemic cardiomyopathies (50,51). Howev-
er, cardiac pathologies characterized by diffuse
myocardial ﬁbrosis cannot be evaluated adequately by
LGE, as there are no reference regions of normal
myocardium. Figure 8 shows LGE images and his-
tology from MI and dilated cardiomyopathy. In MI,
LGE images show focal enhancement corresponding
to the dense focal ﬁbrosis in the infarct, whereas in
dilated cardiomyopathy LGE images may not show
any enhancement despite the presence of signiﬁcant
interstitial ﬁbrosis. T1 mapping techniques following
Gd injection have demonstrated potential for evalu-
ation of diffuse myocardial ﬁbrosis and myocardial
Figure 9. Diffuse Fibrosis Is Not Apparent on Conventional LGE Images
Following an inversion pulse, images are obtained in subsequent heartbeats to obtain images at multiple different inversion times during the
same phase of the cardiac cycle. As the inversion time increases the longitudinal magnetization increases due to T1 recovery. (B) The data are
sorted by inversion time and ﬁt to T1 relaxation curves. Pixels with inﬂammation have shorter T1 relaxation times post-contrast and recover
more rapidly (red curve) than regions of normal myocardium. (D) T1 mapping shows 2 epicardial regions with inﬂammation (yellow arrows
and red region of interest). (E) By inverting the pixel values an R1 map can be generated which has a contrast appearance similar to
conventional LGE images. MOLLI ¼ Modiﬁed Look-Locker.
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816inﬁltration. However, the T1 of the myocardium is a
function not only of the amount of ﬁbrosis, but also of
Gd dose, clearance rate, and time after injection.
There has been growing interest in assessing the vol-
ume of distribution of Gd, or extracellular volume
(ECV), as a noninvasive marker of ﬁbrosis by per-
forming T1 mapping before and after either a
continuous infusion or bolus injection of Gd. The Vd
of Gd has also been used as a noninvasive marker of
cardiac amyloidosis (52). Noncontrast T1 mapping,
also referred to as native-T1 mapping, has demon-
strated potential for assessing myocardial edema in
MI similar to work that has been done with T2-
weighted techniques (47). Noncontrast T1 values are
increased in hypertrophic and dilated cardiomyopathy
reﬂecting ﬁbrosis (53), and in cardiac amyloidosis
reﬂecting the presence of inﬁltration by amyloid
protein (52,54,55). T1 mapping and Vdmeasurements may also have potential for better
delineation of peri-infarct zones and for providing a
more quantitative assessment of myocardial scarring.
CMR Techniques for
Quantifying T1 Relaxation Times
There have been a variety of techniques that have
been used to quantify myocardial T1 values (3–5,
56–58). The simplest but least efﬁcient method is
to collect a single image with a given sensitivity to
T1 on each of multiple separate breath-holds and ﬁt
the signal intensities to the T1 recovery curve as
shown schematically in Figure 9. This allows a T1
map to be determined during a speciﬁc phase of the
cardiac cycle but is time consuming because it re-
quires multiple breath-holds and may be subject to
image misregistration between breath-holds. Two
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817techniques are available which acquire all of the data
for a T1 map in a single breath-hold. The traditional
Look-Locker technique collects image data
continuously to create images at different time
points following a T1-weighted inversion prepara-
tion. A limitation of the traditional Look-Locker
techniques is that the heart is in a different phase
of the cardiac cycle on each image, precluding
mapping of a speciﬁc slice as there may be signiﬁ-
cant through plane motion (59). The Modiﬁed
Look-Locker (MOLLI) pulse sequence is a modi-
ﬁcation to the Look-Locker sequence in which
single-shot images are obtained in diastole with 11
different T1 sensitivities over 17 heartbeats. The
data from these diastolic source images are ﬁt to the
T1 recovery function to create a T1 map (Fig. 9).
The MOLLI technique is reproducible, and pro-
duces source images with high SNR (60,61). A
limitation of the standard MOLLI pulse sequence is
the requirement of 17 heartbeats for data acquisi-
tion, which may result in a breath-hold that is too
long for some patients. Several modiﬁcations have
been proposed to reduce the breath-hold duration
needed to collect the data and to reduce the heart-
rate dependence (62,63). Furthermore, robust
nonrigid registration has been introduced, which
minimizes the effect of motion between the images
collected on different heartbeats (64). The majority
of recently published T1 mapping research has uti-
lized 1 of the 3 techniques, or some variation
thereof.
CMR protocols for determining the volume of distri-
bution of Gd. By measuring T1 before and after
either a bolus injection or equilibrium infusion of Gd,
the apparent ECV can be determined by calculating
the Vd of Gd (3,5,58,65). For the continuous infu-
sion method, Gd is given as a continuous low dose
infusion until the T1 in the myocardium and blood
pool are constant. The Vd can then be directly
determined from the T1 values obtained pre-contrast
and at equilibrium according to the following equa-
tion (5,65).
ECV ¼ ð1HctÞl ¼ ð1HctÞ T1post myo  T1pre myo
T1post blood  T1pre blood
The bolus injection method relies on the assumption
that the exchange between the blood pool and
myocardium is fast with respect to Gd clearance from
the blood such that there is equilibrium between the
concentration of Gd in the blood pool and myocar-
dium at each time point following Gd administration
(3,58). The equivalence of these 2 approaches has
been demonstrated (62,66).Clinical application of T1 mapping techniques. The
reported normal T1 relaxation times for the
myocardium at 1.5-T range between 900 and
1,100 ms with some variation based on technique
(59–61,63,66,67) Pre-contrast measurement of T1
should be increased in myocardial edema similar to
T2 due to the increase in free water content of the
tissue. A study of 8 patients who underwent pre-
contrast T1 mapping demonstrated an 18% increase
in T1 in infarcted regions (68). The area of increased
T1 pre-contrast had a larger spatial extent as
compared to the region of LGE (68). Pre-contrast
T1 measurements have been compared to T2 mea-
surements as an alternative for assessing the “area at
risk” following acute ischemic injury and produce
results similar to microsphere measurements (47).
Pre-contrast T1 times are prolonged in both the
myocardium and blood pool of subjects with
amyloidosis as compared to normal volunteers
(52,55). A recent study of 53 patients with AL
amyloidosis demonstrated a signiﬁcant prolongation
of non-contrast T1 time in cardiac light-chain
amyloidosis patients (1,140  61 ms) as compared
to 36 normal subjects (958  20 ms). A T1 cutoff
of 1,020 yielded 92% accuracy for identifying pa-
tients with possible or deﬁnite cardiac involvement
(54). There was no signiﬁcant difference in non-
contrast T1 values between the controls and 17
subjects with aortic stenosis (979  51 ms). Native
T1 was also shown to be prolonged in cardiomy-
opathy in a study of 25 patients with known hy-
pertrophic cardiomyopathy and 27 subjects with
non-ischemic dilated cardiomyopathy as compared
to 30 control subjects (53).
T1 mapping post-contrast has demonstrated
potential for evaluation of MI. In the same afore-
mentioned study of 8 subjects with MI who un-
derwent T1 mapping pre-contrast, there was a 27%
reduction in post Gd contrast T1, with a spatial
extent which correlated well with LGE, demon-
strating that T1 mapping could be an alternative for
quantifying MI (68). An image of R1, which is
deﬁned as 1/T1, will have an appearance similar to
conventional LGE images where regions of ﬁbrosis
or inﬁltration are bright (Figs. 9C and 9D).
T1 mapping has demonstrated the potential for
assessing diffuse ﬁbrosis and inﬁltration. In a study of
25 patients with heart failure, the T1 times in the
myocardium after Gd contrast were reduced
compared to 20 normal controls, and the post-
contrast T1 times were correlated with the histolog-
ical severity of ﬁbrosis in 9 subjects who underwent
myocardial biopsy (4). This study demonstrated that
post-contrast T1 mapping could potentially be used
Figure 10. Mapping of Myocardial Extracellular Volume
Examples illustrating excellent agreement between late gadolinium enhancement (LGE) and extracellular volume (ECV) in cases of focal
abnormalities in myocardial ECV. Pre-contrast T1-maps (top row), post-contrast T1 maps (second row), late gadolinium enhancement (third
row), and ECV maps (bottom row) for patients with (A) chronic myocardial infarction (MI), (B) acute myocarditis, and (C) hypertrophic
cardiomyopathy (HCM). Adapted from Kellman et al. (71).
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818to evaluate diffuse ﬁbrosis in cardiomyopathy. A
study of 54 heart failure patients undergoing endo-
myocardial biopsy demonstrated a reduction in the
10-min post-contrast T1 time in the heart failure
subjects as compared with 13 controls. In heart fail-
ure, the post-contrast T1 time was inversely corre-
lated with the histological severity of ﬁbrosis (69). T1
mapping post-contrast has also shown potential for
the evaluation of cardiac amyloidosis (70). In 29
patients with proven cardiac amyloidosis a T1 dif-
ference of 23 ms between the subepicardium and
subendocardium at 2 min after Gd administration
predicted mortality in amyloidosis with 85% accuracy
(70). In a study of 5 patients with amyloidosis, therewas also a smaller difference in T1 relaxation times
between the blood pool andmyocardium 17.1 54.3
ms versus 136.1  18.4 ms at 20 min after contrast
administration as compared with 8 controls (52).
By measuring T1 before and after either a bolus or
equilibrium infusion of Gd, the partition coefﬁcient
and volume of distribution of Gd can be assessed, and
they are proportional to the ECV (Fig. 10). TheECV
of normal myocardium has been reported to be in the
range of 24% to 28% (56,62,66,71). Assessment of
Vd or the partition coefﬁcient lambda has been used
to assess diffuse ﬁbrosis in different cardiac pathol-
ogies. In 9 patients with dilated cardiomyopathy, the
Vd of Gd was found to be signiﬁcantly increased in
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819patients with both familial and dilated cardiomyop-
athy (3). Similar ﬁndings were demonstrated in
congenital heart disease with myocardial dysfunction
(56). Validation of the correlation between the Vd
and histological evidence of myocardial ﬁbrosis has
been performed in 18 subjects with aortic stenosis
undergoing aortic valve replacement and in 18 pa-
tients with HCM undergoing surgical myectomy
using a multi–breath-hold equilibrium infusion T1
technique (5). Given the prognostic data available in
HCM for the evaluation of focal ﬁbrosis with LGE, it
is likely that T1 mapping may provide additional
disease in this disease as it reﬂects both focal and
diffuse ﬁbrosis (72).
The Vd and the partition coefﬁcient of Gd are
markedly increased in amyloid cardiomyopathy with
expansion of the extracellular space due to amyloid
protein deposition (55,73). The degree of change in
Vd is much larger than the changes in the individual
T1 measurements of the blood pool and myocar-
dium. This may serve as a new marker for deter-
mining disease burden in amyloid cardiomyopathy.
A direct comparison of ECV determined at
1.5- and 3-T in 31 patients demonstrated similar
ECV measurements between these 2 ﬁeld strengths.
However, the investigators noted differences in
ECV between the septum and lateral wall, which
may be related to susceptibility and will likely be
more problematic at higher ﬁeld strengths (74).
Using the pre- and post-contrast T1-maps, one
can generate parametric images of Vd which reﬂect
the ECV (Fig. 10), thus providing a new type of
image contrast which may provide insight into
diseases characterized by regional differences in
ﬁbrosis (71). ECV mapping may also have impor-
tant prognostic signiﬁcance in different cardiac pa-
thologies (75).
The development of robust techniques for non-
rigid registration has greatly improved the clinical
applicability of T1 mapping, as T1 maps can be
generated without the need for user interaction (64).
Further developments in parallel and compressed
sensing techniques will further improve the spatial
and temporal resolution of parametric mapping.
Potential clinical pitfalls and solutions. It is impor-
tant to note that the MOLLI T1 mapping pulsesequences have some heart rate dependence which
may bias measured T1 relaxation times particularly
in patients with fast heart rates. As this bias is T1
dependent, the effect is worse for pre-contrast T1
times where the T1 relaxation times are on the order
of 1 to 1.5 s. For the MOLLI pulse sequence this
effect can be mitigated to an extent by increasing the
number of relaxation heartbeats; however, this
directly increases the required breath-hold. Second,
the speciﬁc parameters of the SSFP readout module
can also introduce some T2 dependence to the
measured T1 values. Thus, some caution is war-
ranted when comparing T1 measurements acquired
by different methodologies.
Conclusions. Quantitative techniques for myocar-
dial perfusion and parametric mapping of magnetic
relaxation times are extending the unique potential
of CMR for characterization of cardiac structure
and physiology. There is a growing body of evidence
for the clinical utility of quantitative assessment of
perfusion and relaxation times, although current
techniques still have some important limitations.
There are signiﬁcant differences in the techniques
used for both image acquisition and image analysis
between MRI vendors and different sites. Stan-
dardization of acquisition and analysis will be
important for the wider clinical applicability of
these techniques. Improved scanner technology and
reconstruction and image processing techniques are
rapidly evolving which will further improve the
available techniques for CMR parametric mapping.
Further research will be necessary to demonstrate
that these new techniques will offer incremental
diagnostic and prognostic utility and robustness as
compared to current visual and semiquantitative
CMR techniques.Acknowledgment
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